• Toxoplasma gondii Antibody, IgA
  • Fetal Fibronectin (fFN)
  • Hepatocellular carcinoma
  • ABO Group and Rh Typing
  • Acanthamoeba and Naegleria Culture and Stains, Corneal Scraping
  • Protein S Activity
  • Arginine Vasopressin Hormone
  • ToRCH Panel, IgG
  • Myelin Basic Protein, CSF
  • Osmolality, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Additional ICD10
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.